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Abstract
Keratoconus is a bilateral, non-inflammatory, degenerative corneal disease. The occurrence and development of
keratoconus is associated with corneal thinning and conical protrusion, which causes irregular astigmatism. With
the disruption of the collagen organization, the cornea loses its shape and function resulting in progressive visual
degradation. Currently, corneal topography is the most important tool for the diagnosis of keratoconus, which may
lead to false negatives among the patient population in the subclinical phase. However, it is now hypothesised that
biomechanical destabilisation of the cornea may take place ahead of the topographic evidence of keratoconus,
hence possibly assisting with disease diagnosis and management. This article provides a review of the definition,
diagnosis, and management strategies for keratoconus based on corneal biomechanics.
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Background
Keratoconus (KC) is an idiopathic degenerative eye dis-
ease characterised by localized thinning and conical pro-
trusion of the cornea, which typically develops in the
inferior-temporal and central zones [1]. Consequently,
visual acuity is reduced due to irregular astigmatism and
high myopia resulting from asymmetric topographical
changes in the anterior corneal surface. KC is the most
prevalent form of corneal ectasia and affects all ethnici-
ties [2–5], however, higher incidence has been reported
in Asians when compared to Caucasians [6, 7]. While
the aetiology and pathology of the disease is still not
fully understood, various biochemical, cellular and
microstructural differences have been reported in the
literature. For instance, biochemical changes include in-
creased activity of proteolytic enzymes and a decrease in
their inhibitors [8, 9]. Increased proteoglycan (PG) con-
tent and altered distribution PG filaments have also been
reported [10]. A progressive reduction in collagen-
producing corneal keratocytes has been observed [11] as
well as a disruption to the highly organized orthogonal
arrangement of collagens [12] that is typically seen in
healthy corneas [13, 14]. Further, a decrease in the mean
fibril diameter and interfibrillar spacing of individual
collagens and undulation of collagen lamellae have been
reported [10]. Since biomechanical stability is dependent
on regulation and organization of structural components
within the cornea, the aforementioned biochemical,
cellular and microstructural alterations would be ex-
pected to have negative consequences on structural in-
tegrity and hence lead to corneal abnormal deformation
under intraocular pressure. It is therefore no surprise
that experimental studies of ex vivo KC corneas have
reported abnormalities in biomechanical response to ap-
plied loads when compared to normal corneas [15, 16].
Reviews
Keratoconus diagnosis techniques
With the disruption of the collagen network, intraocular
pressure-related stress causes a weakened cornea to
bulge from its normal shape and become progressively
conical. Consequently, corneal topography is the most
widely used tool to detect KC [17]. Corneal shape pa-
rameters such as thin pachymetry, atypical pachymetry
profile, irregular anterior curvature as well as increased
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posterior surface elevation, have all been used to detect
KC at different stages of the disease [17]. While topog-
raphy analysis is well-suited to characterising KC when
clear geometrical changes have occurred in the cornea,
its robustness reduces when attempting to assess mild,
pathologic cases, especially in subclinical or early KC
[17]. However, changes in corneal geometric features are
secondary signs of KC whereas the earliest initiating
changes would occur within the microstructures and then
the biomechanical properties of cornea. Therefore, under-
standing the cornea’s biomechanical behaviour is import-
ant for the detection of subclinical KC, while changes in
topography are still insufficient to provide conclusive evi-
dence of KC progression [18]. However, in vivo measure-
ment of corneal biomechanics remains a difficult task at
this stage and only two commercially available instru-
ments have been proposed to assist in the diagnosis of
KC. These two instruments are summarized below.
Ocular response analyzer
The ocular response analyzer (ORA) became commer-
cially available in 2005 and was the first device capable
of evaluating the biomechanical response of the cornea
in vivo (Fig. 1). The device provides two biomechanical
metrics: corneal hysteresis (CH) and corneal resistance
factor (CRF), both of which are influenced by the visco-
elastic behaviour of corneal tissue [19]. Clinically mea-
sured metrics provided by the ORA have been widely
used to assess the biomechanical response of the cornea.
Compared with normal patients, both CH and CRF de-
crease in KC corneas indicating mechanical softening of
the stroma [20]. However, when comparing these bio-
mechanical metrics, it is clear that a wide substantial
overlap exists between normal corneas and keratoconic
corneas [21, 22] and so they have not been as effective
in identifying KC as first anticipated. Furthermore, the
exact correlation between these metrics and the estab-
lished mechanical properties of tissue (such as tangent
modulus) is still unknown. Thus, the ORA needs to be
complemented with other diagnostic imaging tools to
obtain a reliable diagnosis of KC. With the introduction
of a new software update (version 2.0) in 2009, the ORA
now computes 37 new parameters that describe the
waveform of the ORA applanation signal. These parame-
ters show promise in providing additional biomechanical
information about the KC cornea [23, 24]. However, spe-
cific explanation of the meaning of these parameters has
not been provided by the manufacturers, and they still
require thorough clinical validation before they can be
used clinically.
Corvis ST
The Corvis ST (CVS) is another non-contact device that
was introduced in 2010 and provides information about the
biomechanical response of the cornea using dynamic
Scheimpflug imaging analysis (Fig. 2). The CVS captures
approximately 140 cross-sectional images of the cornea
during the air-puff induced dynamic deformation [25] using
its high-speed camera system. The corneas’ response to air
pressure is characterized by ten deformation parameters,
some of which are strongly correlated with the tissue’s
mechanical stiffness. As shown in a previous study, the
maximum deformation amplitude of keratoconic corneas is
much greater than that of normal corneas [26]. However,
the usefulness of CVS to evaluate KC severity and diagnose
Fig. 1 Photo of the Ocular Response Analyzer (ORA) Fig. 2 Photo of the Corvis ST (CVS)
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subclinical KC is yet to be determined. In addition to the
ten metrics provided by the device, the inclusion of a high-
speed Scheimpflug camera allows for precise monitoring of
cornea cross-sectional deformation under the applied air
pressure. The capability to monitor in vivo response of the
cornea provides biomedical engineers with essential infor-
mation that can be used to determine more precise
biomechanical properties of the tissue. Work is now pro-
gressing to utilise this device to produce regional estima-
tions of in vivo corneal stiffness, which may allow for better
planning of the treatment and management of KC.
Other devices
In addition to the ORA and CVS, several other technolo-
gies have been developed to evaluate corneal biomechanical
parameters in vivo such as optical coherence tomography
[27], supersonic shear wave imaging (SSI) [28], confocal mi-
croscopy [29], applanation resonance tonometry (ART)
[30], acoustic radiation force (ARF) [31] and scanning
acoustic microscopy [32]. However, validation of these
technologies in human eyes will be essential before using
them to improve the accuracy of KC diagnosis.
The current lack of reliable devices that are capable of
characterising true corneal material properties in vivo
has meant that the biomechanics of KC have only been
investigated to a limited extent. It is now becoming evi-
dent that a global biomechanical assessment of the cor-
nea may not be sufficient to fully characterize this
typically asymmetric disease. Spatial location of focal
weakening in the cornea will be necessary to detect the
disease at its early stages as well as fully characterise its
progression.
Keratoconus management techniques
KC is currently managed using a number of methods
ranging from contact lenses to intra-stromal corneal ring
segment (ICRS) implants and collagen crosslinking
(CXL), penetrating keratoplasty (PK) and deep anterior
lamellar keratoplasty (DALK). However, the method of
management used is dependent on the severity of the
ectasia. In early stages, spectacles can correct refractive
errors sufficiently. As the disease progresses [2], this
method becomes unsuitable for correcting the irregular
astigmatism associated with KC. In mild to moderate
KC, contact lenses have become the most common and
successful method of management providing improved
visual acuity whilst decreasing the need for surgical in-
terventions [33]. Although soft lenses provide increased
comfort for the wearer, rigid lenses are more prevalent
since high levels of irregular astigmatism cannot be cor-
rected with other lens types [34, 35]. Recently, CXL
treatment of the cornea is becoming the standard
method for halting the progression of the disease at early
stages and prevent further deterioration, which may
make tissue replacement necessary. PK and more
recently, DALK, are used to replace either the entire
cornea or 95 % of the stromal layers of the cornea, re-
spectively, with healthy donor tissue in advanced cases
of KC that cannot be successfully managed with other
methods.
Contact lenses
Contact lenses aim to improve the anterior curvature of
the cornea and increase visual acuity. The lens is held in
place by forces generated between the tear film, lens and
eye, and several options are currently available for use
on keratoconic corneas. Bespoke soft lens options, such
as the KeroSoft® lens, are individually lathe cut to fit the
specific irregularity of a patients’ cornea resulting in a
close fit between the lens and eye. Rigid lenses are made
from oxygen permeable material but the degree of fit
between the lens and eye varies. Originally, it was hoped
that the lens bearing pressure on the cornea could
correct or stabilise the ectasia by flattening the cone (flat
fit) [36], but this can result in abrasion and scarring of
the cornea [37] as well as progression of the cone. In
mild KC, an ideal fit can be achieved and the lens is
usually intended to rest on the apex of the cone and
peripheral cornea (three-point touch). However, as the cone
progresses, a compromised fit may need to be accepted as
long as it does not cause damage to the cornea [38].
Intra-stromal corneal ring segments
In contrast to the spectacles and contact lens short-term
solutions, which aim to improve visual acuity by improv-
ing the anterior curvature of the cornea, more long-term
invasive clinical interventions are available. ICRS im-
plants aim to improve the shape of the cornea and halt
the progression of the cone. ICRS implants are inserted
into the stroma by creating an incision in the peripheral
region of the cornea and decrease asymmetrical astigma-
tism and convexity of the cone [39, 40]. Although there
have been no statistically significant differences observed
in CH and CRF parameters obtained from the ORA fol-
lowing use of the ICRS [41], the introduction of rigid
components to the stroma would be expected to affect
the biomechanical behaviour of the tissue. This could be
due to tissue scarring within the stroma resulting from
the introduction of the ICRS implants or changes in the
overall mechanical response of the tissue, particularly in
the peripheral region where the implant has been
introduced.
Corneal collagen cross-linking
CXL is commonly achieved by removing the epithelium
and saturation of the stroma with riboflavin followed by
irradiation of the central region of the cornea using
ultraviolet-A light at 365–370 nm [42]. The procedure
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induces crosslinks between the collagen fibrils and
within the proteoglycan-rich coating surrounding them
[43] as well as limited linkages among collagen mole-
cules and among proteoglycan core proteins [44]. The
outcome of this procedure is an overall increase in
mechanical strength [45], which usually halts the pro-
gression of the cone [46]. CXL is now fast becoming the
most commonly used technique as it can be used to halt
the progression of the cone especially at an early stage
[47] and with minimum stromal thickness of at least
400 μm, thereby reducing further degradation of visual
acuity and limiting the need for corneal transplants.
Keratoplasty
Advanced cases of KC with high corneal curvature, high
astigmatism, low visual acuity, presence of corneal scar-
ring and/or poor contact lens tolerance may require PK
[48–50], in which the entire thickness of the cornea is
removed and replaced by healthy corneal tissue [2, 48].
However, normal stromal architecture cannot be fully
recovered in full-thickness graft wounds [51–53]. On the
other hand, if Descemet’s membrane and the endothe-
lium are to remain intact [54, 55], DALK should be a
reasonable alternative [56], in which only the stromal
layers of the cornea are removed and replaced thereby
reducing the risk of endothelial rejection and transplant
failure. Nevertheless, long-term abnormalities in colla-
gen fibril orientation and spatial organisation around the
entire graft margin have been observed following PK,
which may affect corneal biomechanical behaviour and
graft stability in the long term [57].
Biomechanical changes in KC with different management
techniques
Although all current KC management techniques in-
volve mechanical interaction with or mechanical changes
to the cornea, the design and planning of these interven-
tions do not consider the mechanical properties of the
cornea either pre- or post-intervention. For instance,
possible hypoxic effects can occur from prolonged lens
wear resulting in oedema [58], and hence increased
thickness with soft contact lenses even though the mate-
rials used have high oxygen permeability. In rigid lens
wear, where the interaction between the lens and cornea
can be even more pronounced, changes in corneal shape
with possible biochemical, cellular and microstructural
responses may have subsequent consequences for the
overall biomechanical integrity of the cornea. Postopera-
tive ORA assessments have shown that DALK treated
corneas return to biomechanical metrics similar to those
of normal corneas whereas the corresponding values for
PK treated corneas are significantly lower, indicating
weaker biomechanical properties [59, 60]. However, the
most significant changes observed are those obtained
using CXL. Experimental crosslinking studies have re-
ported human corneal stiffness increases in the region of
300 % using riboflavin/UVA treatment [45], but surpris-
ingly no change in inter-laminar cohesion [61]. These
changes in corneal stiffness could not be properly vali-
dated so far in vivo due to limitations with current clin-
ical biomechanical assessment techniques as discussed
in this paper.
Conclusion
The current inability to measure in vivo corneal biomech-
anical properties has been a major obstacle in planning and
assessing the outcomes of KC interventions. While diagno-
sis techniques rely on abnormal cornea tomography param-
eters, changes in corneal geometry are secondary signs of
the disease. Consequently, the efficacy of using these pa-
rameters is reduced when attempting to assess mild and
subclinical cases. Since the earliest changes to KC corneas
occur within the microstructure, in vivo assessment of cor-
neal biomechanics may be a more appropriate approach to
detecting subclinical KC. The ORA and CVS provide the
first step towards the assessment of in vivo of biomechan-
ical properties. In particular, the inclusion of a high-speed
Scheimpflug camera on the CVS allows detailed monitoring
of the corneas response to an applied air pressure. This in-
valuable information may be used by biomedical engineers
to determine more detailed corneal biomechanical proper-
ties and develop a method of identifying the spatial location
of focal weakening within the tissue, and hence enable early
detection of subclinical KC and optimisation of manage-
ment techniques to individual patient’s needs.
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